haematology

News in brief: PBS listing recommended for T-cell lymphoma therapy; Australian cases of CLL occurring concurrently with CML

PBS listing recommended for T-cell lymphoma treatment Brentuximab vedotin (Adcetris) has received a positive recommendation for PBS listing for the treatment of patients with previously untreated CD30 positive peripheral T-cell lymphoma, when used in combination with cyclophosphamide, doxorubicin, and prednisone (CHP). The Pharmaceutical Benefits Advisory Committee (PBAC) accepted that BV+CHP was clinically superior in terms ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic